ELI LILLY AND COMPANY |
Market Closed -
Other stock markets
|
After market 05:23:46 am | |||
| 764 USD | +0.83% |
|
762.2 | -0.23% |
| 14/05 | Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs | RE |
| 14/05 | Argus Adjusts Price Target on Eli Lilly to $840 From $770 | MT |
ETFs positioned on Eli Lilly and Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.29% | 36 M€ | +2.97% | - | |
| 0.27% | 1 M€ | -.--% | - | |
| 0.24% | 12 M€ | +13.22% | - | |
| 0.23% | 17 M€ | +4.20% | - | |
| 0.22% | 105 M€ | +3.32% | - | |
| 0.21% | 7 M€ | +6.18% | - | |
| 0.21% | 32 M€ | +1.80% | - | |
| 0.21% | 17 M€ | +6.18% | - | |
| 0.20% | 253 M€ | +7.47% | ||
| 0.19% | 17 M€ | +2.84% | - | |
| 0.18% | 20 M€ | +1.33% | - | |
| 0.17% | 32 M€ | +0.82% | - | |
| 0.15% | 2 M€ | +4.43% | - | |
| 0.15% | 234 M€ | +3.34% | - | |
| 0.11% | 2 M€ | +3.16% | - | |
| 0.11% | 23 M€ | +12.87% | - | |
| 0.11% | 54 M€ | +0.39% | - | |
| 0.10% | 756 M€ | +0.15% | - | |
| 0.09% | 8 M€ | +0.60% | - | |
| 0.08% | 6 M€ | -4.26% | - | |
| 0.08% | 3 M€ | +5.91% | - | |
| 0.02% | 104 M€ | +9.47% |
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
764
USD
Average target price
850.4
USD
Spread / Average Target
+11.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.06% | 68TCr | |
| +30.35% | 59TCr | |
| -3.42% | 36TCr | |
| +18.02% | 33TCr | |
| +4.27% | 28TCr | |
| +15.53% | 24TCr | |
| +10.16% | 21TCr | |
| -8.14% | 20TCr | |
| +8.12% | 17TCr | |
| -1.42% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- Funds and ETFs Eli Lilly and Company